CCPoint® - Part of the Rheumatology Screening Project

August 16, 2013 - Company News, Product News, Disease Area News
Euro Diagnostica is pleased to announce that our rapid test for anti-CCP2 autoantibodies CCPoint® will be a part of an extensive German healthy prevention project called "RWE Rheuma Truck 2013". The project is planned and organized by the Cooperative Rheumatology Association Rhein-Ruhr (RZRR) in Düsseldorf with the aim to early detect inflammatory rheumatic diseases of German employees of the multi-national energy corporation RWE.

In brief the RZRR and RWE in co-operation have hired a 32 ton show truck (Rheuma Truck) and made it into a rheumatologic outpatient clinic.

The truck is equipped with validated RheumaCheck and BackCheck questionnaires and also Euro Diagnostica´s rapid blood test for anti-CCP2 antibodies, CCPoint®. During August and September 2013 the Rheuma Truck will travel to 30 RWE locations throughout Germany to test approximately 4 000 RWE employees for inflammatory rheumatic diseases.

CCPoint® is a point-of-care test, which provides a reliable answer on the presence of anti-CCP2 autoantibodies from a small drop of blood within 10 minutes. Euro Diagnostica´s different CCP test systems are worldwide recognized as the golden standard for anti-CCP2 autoantibody testing.

For further information about the Rheuma Truck project, please click on this link.

Euro Diagnostica and CCP2-testing

The determination of autoantibodies to cyclic citrullinated proteins/peptides (anti-CCP autoantibodies) are of high importance in the diagnosis of rheumatoid arthritis and part the ACR/EULAR* classification criteria1. Since it has been shown that anti-CCP autoantibodies often are present in the sera several years prior to the first symptoms anti-CCP tests are excellent early markers for inflammatory rheumatic diseases2.

Together with world class leading scientists Euro Diagnostica was first to develop and produce ELISA tests for anti-CCP autoantibodies. Our anti-CCP2 ELISA kit Immunoscan CCPlus® is now recognized as the golden standard of testing for anti-CCP3. Our CCPoint® test was the first anti-CCP point-of-care test, and reliable test results are provided within 10 minutes. The overall agreement of CCPoint® Immunoscan CCPlus® is 99.6% (N = 1052 samples)4.

Today, the majority of anti-CCP2 tests in the world are supplied by Euro Diagnostica.

Further information regarding our anti-CCP tests and other autoantibody products are available via:

CCPoint (link)

CCPlus Immunoscan (link)

*ACR = American College of Rheumatology, EULAR = The European League against Rheumatism


1. Aletaha et al. Arthritis Rheum. 2010 Sep;62(9):2569-81

2. Rantapaa-Dahlqvist et al, Arthritis Rheum.48, 2741–2749 (2003)

3. Pruijn et al. Arthritis Research & Therapy 2010, 12:203

4. IFU CCPoint®, September 2011


About Euro Diagnostica

Euro Diagnostica - a leader in autoimmunity testing provides complete diagnostic solutions and offers also customized coating services. Wieslab Lab Services, an integral part of Euro Diagnostica, offers testing services for most autoimmune diseases.

During the last two decades, our world class scientists have been the first to develop and produce top quality ELISA kits for ANCA, anti-CCP, Chromogranin and Complement assays, which are now in use all over the world.

Euro Diagnostica combines a long tradition in R&D with a commitment to quality. Euro Diagnostica’s goal is to constantly develop solutions to aid clinicians in diagnosis, prognosis, monitoring and treatment of autoimmune and related diseases.

Euro Diagnostica receives the 2013 European Autoimmune Disease Diagnostics Product Differentiation Award from Frost & Sullivan:

« Back